Regeneron Pharmaceuticals Stock Price and Value Analysis

Should you buy Regeneron Pharmaceuticals stock? (NasdaqGS:REGN). Let's see how it does in our automated value investing analysis system.

REGN Free Cash Flow Trend

Free Cash Flow trendline for REGN
Free Cash Flow trendline for Regeneron Pharmaceuticals

Based on historical returns, we believe that Regeneron Pharmaceuticals can grow its free cash at a rate of about 2%. That's positive!

  • This stock looks overpriced.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This company is making money at a modest rate.
  • This company pays no dividend.

Inside the REGN Numbers

REGN Price
(Regeneron Pharmaceuticals stock price per share)
[?] REGN Fair Price
(based on intrinsic value)
[?] REGN Safety Price (based on a variable margin of safety) $48.77
[?] PE Ratio versus Sector 55% higher than other Healthcare stocks
[?] PE Ratio versus Industry 45% lower than other Biotechnology stocks
[?] Cash Yield 0.72%
[?] Free Cash Flow Jitter 48%

Is Regeneron Pharmaceuticals Stock on Sale?

We believe that Regeneron Pharmaceuticals may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Regeneron Pharmaceuticals looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy REGN Stock?

Does Regeneron Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.